ArticleACS medicinal chemistry letters2022

Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK2.

Minh H Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.